Pfizer Inc. (NYSE:PFE) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received an average recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and three […]
Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received an average recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and three […]
